Cipla Q4 results preview: Revenue, PAT may post double-digit growth, EBITDA margins likely to expand
Stock price of Cipla will be trending on Friday as the pharma major is set to announce its financial results for the fourth quarter of FY23.
Pharma major, Cipla will be in focus on Friday ahead of its Q4 numbers. The company is expected to report double-digit growth in the bottom-line and top-line front for the quarter. Also, EBITDA margins are expected to improve ahead. Cipla has a strong product launch pipeline which is expected to play out well for the company ahead.
Get the best recommendations on Stocks, Mutual Funds and more based on your Risk profile!Let’s get started